FDA Inspection 1334084 — CMIC Pharma Science Co., Ltd.

CMIC Pharma Science Co., Ltd. — FEI 3011029035

The FDA completed an inspection of CMIC Pharma Science Co., Ltd. on Sep 3, 2026 in Ishikari. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 3, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ishikari (Japan)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.